nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCC2—type 2 diabetes mellitus	0.439	1	CbGaD
Sparfloxacin—ABCC2—Glyburide—type 2 diabetes mellitus	0.0662	0.219	CbGbCtD
Sparfloxacin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0654	0.216	CbGbCtD
Sparfloxacin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0583	0.193	CbGbCtD
Sparfloxacin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0422	0.139	CbGbCtD
Sparfloxacin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.029	0.0958	CbGbCtD
Sparfloxacin—ABCB1—Glyburide—type 2 diabetes mellitus	0.0216	0.0714	CbGbCtD
Sparfloxacin—ABCB1—Losartan—type 2 diabetes mellitus	0.0197	0.0653	CbGbCtD
Sparfloxacin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00181	0.724	CbGdCrCtD
Sparfloxacin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00069	0.276	CbGdCrCtD
Sparfloxacin—Lomefloxacin—ABCC2—type 2 diabetes mellitus	0.000612	0.176	CrCbGaD
Sparfloxacin—Ofloxacin—ABCC2—type 2 diabetes mellitus	0.000523	0.151	CrCbGaD
Sparfloxacin—Gatifloxacin—ALB—type 2 diabetes mellitus	0.000439	0.126	CrCbGaD
Sparfloxacin—Lomefloxacin—CYP1A2—type 2 diabetes mellitus	0.000408	0.118	CrCbGaD
Sparfloxacin—Ofloxacin—CYP1A2—type 2 diabetes mellitus	0.000349	0.101	CrCbGaD
Sparfloxacin—Levofloxacin—CYP1A2—type 2 diabetes mellitus	0.000349	0.101	CrCbGaD
Sparfloxacin—Ciprofloxacin—CYP1A2—type 2 diabetes mellitus	0.000337	0.0971	CrCbGaD
Sparfloxacin—Levofloxacin—CYP3A4—type 2 diabetes mellitus	0.000231	0.0666	CrCbGaD
Sparfloxacin—Ciprofloxacin—CYP3A4—type 2 diabetes mellitus	0.000223	0.0643	CrCbGaD
Sparfloxacin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00011	0.000509	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00011	0.000508	CcSEcCtD
Sparfloxacin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000109	0.000507	CcSEcCtD
Sparfloxacin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000506	CcSEcCtD
Sparfloxacin—Myalgia—Metformin—type 2 diabetes mellitus	0.000109	0.000505	CcSEcCtD
Sparfloxacin—Chest pain—Metformin—type 2 diabetes mellitus	0.000109	0.000505	CcSEcCtD
Sparfloxacin—Malaise—Irbesartan—type 2 diabetes mellitus	0.000109	0.000505	CcSEcCtD
Sparfloxacin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000109	0.000503	CcSEcCtD
Sparfloxacin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000108	0.000502	CcSEcCtD
Sparfloxacin—Discomfort—Metformin—type 2 diabetes mellitus	0.000108	0.000499	CcSEcCtD
Sparfloxacin—Nausea—Glipizide—type 2 diabetes mellitus	0.000107	0.000497	CcSEcCtD
Sparfloxacin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000107	0.000497	CcSEcCtD
Sparfloxacin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000495	CcSEcCtD
Sparfloxacin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000107	0.000495	CcSEcCtD
Sparfloxacin—Pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.000495	CcSEcCtD
Sparfloxacin—Tremor—Losartan—type 2 diabetes mellitus	0.000107	0.000493	CcSEcCtD
Sparfloxacin—Rash—Glimepiride—type 2 diabetes mellitus	0.000106	0.000493	CcSEcCtD
Sparfloxacin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000106	0.000492	CcSEcCtD
Sparfloxacin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000491	CcSEcCtD
Sparfloxacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000106	0.000491	CcSEcCtD
Sparfloxacin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000106	0.000491	CcSEcCtD
Sparfloxacin—Headache—Glimepiride—type 2 diabetes mellitus	0.000106	0.000489	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.000489	CcSEcCtD
Sparfloxacin—Cough—Irbesartan—type 2 diabetes mellitus	0.000105	0.000488	CcSEcCtD
Sparfloxacin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000488	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000105	0.000484	CcSEcCtD
Sparfloxacin—Agitation—Losartan—type 2 diabetes mellitus	0.000104	0.000484	CcSEcCtD
Sparfloxacin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000104	0.000484	CcSEcCtD
Sparfloxacin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000104	0.000483	CcSEcCtD
Sparfloxacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000482	CcSEcCtD
Sparfloxacin—Angioedema—Losartan—type 2 diabetes mellitus	0.000104	0.000481	CcSEcCtD
Sparfloxacin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000104	0.000481	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.000479	CcSEcCtD
Sparfloxacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Sparfloxacin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Sparfloxacin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Sparfloxacin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Sparfloxacin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000477	CcSEcCtD
Sparfloxacin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000103	0.000475	CcSEcCtD
Sparfloxacin—Malaise—Losartan—type 2 diabetes mellitus	0.000103	0.000475	CcSEcCtD
Sparfloxacin—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000102	0.000475	CcSEcCtD
Sparfloxacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000102	0.000475	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000102	0.000474	CcSEcCtD
Sparfloxacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000474	CcSEcCtD
Sparfloxacin—Vertigo—Losartan—type 2 diabetes mellitus	0.000102	0.000473	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000473	CcSEcCtD
Sparfloxacin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000102	0.000473	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—AVP—type 2 diabetes mellitus	0.000102	0.00275	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000102	0.000472	CcSEcCtD
Sparfloxacin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000102	0.000471	CcSEcCtD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—APOA1—type 2 diabetes mellitus	0.000101	0.00274	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000101	0.000468	CcSEcCtD
Sparfloxacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000101	0.000468	CcSEcCtD
Sparfloxacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000466	CcSEcCtD
Sparfloxacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000101	0.000466	CcSEcCtD
Sparfloxacin—Palpitations—Losartan—type 2 diabetes mellitus	0.0001	0.000465	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—type 2 diabetes mellitus	0.0001	0.00271	CbGpPWpGaD
Sparfloxacin—Nausea—Glimepiride—type 2 diabetes mellitus	0.0001	0.000464	CcSEcCtD
Sparfloxacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.0001	0.000463	CcSEcCtD
Sparfloxacin—Nausea—Sitagliptin—type 2 diabetes mellitus	9.98e-05	0.000463	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	9.98e-05	0.0027	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000462	CcSEcCtD
Sparfloxacin—Asthenia—Glyburide—type 2 diabetes mellitus	9.98e-05	0.000462	CcSEcCtD
Sparfloxacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.97e-05	0.000462	CcSEcCtD
Sparfloxacin—Anorexia—Metformin—type 2 diabetes mellitus	9.96e-05	0.000461	CcSEcCtD
Sparfloxacin—Cough—Losartan—type 2 diabetes mellitus	9.92e-05	0.00046	CcSEcCtD
Sparfloxacin—Urticaria—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.00046	CcSEcCtD
Sparfloxacin—Alopecia—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000458	CcSEcCtD
Sparfloxacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.000457	CcSEcCtD
Sparfloxacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.87e-05	0.000457	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000457	CcSEcCtD
Sparfloxacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.85e-05	0.000457	CcSEcCtD
Sparfloxacin—Pruritus—Glyburide—type 2 diabetes mellitus	9.84e-05	0.000456	CcSEcCtD
Sparfloxacin—Constipation—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000455	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	9.74e-05	0.00263	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	9.71e-05	0.00263	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	9.71e-05	0.00263	CbGpPWpGaD
Sparfloxacin—Pain—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000449	CcSEcCtD
Sparfloxacin—Myalgia—Losartan—type 2 diabetes mellitus	9.68e-05	0.000448	CcSEcCtD
Sparfloxacin—Arthralgia—Losartan—type 2 diabetes mellitus	9.68e-05	0.000448	CcSEcCtD
Sparfloxacin—Chest pain—Losartan—type 2 diabetes mellitus	9.68e-05	0.000448	CcSEcCtD
Sparfloxacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.67e-05	0.000448	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.65e-05	0.000447	CcSEcCtD
Sparfloxacin—Anxiety—Losartan—type 2 diabetes mellitus	9.65e-05	0.000447	CcSEcCtD
Sparfloxacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.62e-05	0.000446	CcSEcCtD
Sparfloxacin—Rash—Bromocriptine—type 2 diabetes mellitus	9.59e-05	0.000444	CcSEcCtD
Sparfloxacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.58e-05	0.000444	CcSEcCtD
Sparfloxacin—Tension—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000443	CcSEcCtD
Sparfloxacin—Discomfort—Losartan—type 2 diabetes mellitus	9.56e-05	0.000443	CcSEcCtD
Sparfloxacin—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000442	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000442	CcSEcCtD
Sparfloxacin—Headache—Bromocriptine—type 2 diabetes mellitus	9.53e-05	0.000442	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.52e-05	0.000441	CcSEcCtD
Sparfloxacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.51e-05	0.000441	CcSEcCtD
Sparfloxacin—Nervousness—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000439	CcSEcCtD
Sparfloxacin—Dry mouth—Losartan—type 2 diabetes mellitus	9.47e-05	0.000439	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	9.43e-05	0.00255	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	9.42e-05	0.00255	CbGpPWpGaD
Sparfloxacin—Anorexia—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000435	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.38e-05	0.000435	CcSEcCtD
Sparfloxacin—Paraesthesia—Metformin—type 2 diabetes mellitus	9.38e-05	0.000435	CcSEcCtD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	9.36e-05	0.00253	CbGpPWpGaD
Sparfloxacin—Confusional state—Losartan—type 2 diabetes mellitus	9.36e-05	0.000433	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.35e-05	0.00253	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.35e-05	0.00253	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.34e-05	0.000433	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.33e-05	0.00252	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Metformin—type 2 diabetes mellitus	9.31e-05	0.000432	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	9.29e-05	0.00251	CbGpPWpGaD
Sparfloxacin—Somnolence—Metformin—type 2 diabetes mellitus	9.29e-05	0.00043	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.28e-05	0.00043	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000429	CcSEcCtD
Sparfloxacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.2e-05	0.000426	CcSEcCtD
Sparfloxacin—Dyspepsia—Metformin—type 2 diabetes mellitus	9.2e-05	0.000426	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.18e-05	0.00248	CbGpPWpGaD
Sparfloxacin—Tremor—Ramipril—type 2 diabetes mellitus	9.13e-05	0.000423	CcSEcCtD
Sparfloxacin—Urticaria—Valsartan—type 2 diabetes mellitus	9.11e-05	0.000422	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.08e-05	0.000421	CcSEcCtD
Sparfloxacin—Decreased appetite—Metformin—type 2 diabetes mellitus	9.08e-05	0.000421	CcSEcCtD
Sparfloxacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.07e-05	0.00042	CcSEcCtD
Sparfloxacin—Tachycardia—Losartan—type 2 diabetes mellitus	9.06e-05	0.00042	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.04e-05	0.000419	CcSEcCtD
Sparfloxacin—Nausea—Bromocriptine—type 2 diabetes mellitus	9.04e-05	0.000419	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.02e-05	0.00244	CbGpPWpGaD
Sparfloxacin—Urticaria—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000417	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000416	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.97e-05	0.000416	CcSEcCtD
Sparfloxacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000415	CcSEcCtD
Sparfloxacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000415	CcSEcCtD
Sparfloxacin—Asthenia—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.000415	CcSEcCtD
Sparfloxacin—Agitation—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000415	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	8.94e-05	0.00242	CbGpPWpGaD
Sparfloxacin—Constipation—Metformin—type 2 diabetes mellitus	8.93e-05	0.000414	CcSEcCtD
Sparfloxacin—Angioedema—Ramipril—type 2 diabetes mellitus	8.91e-05	0.000413	CcSEcCtD
Sparfloxacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.00041	CcSEcCtD
Sparfloxacin—Anorexia—Losartan—type 2 diabetes mellitus	8.84e-05	0.00041	CcSEcCtD
Sparfloxacin—Vomiting—Glyburide—type 2 diabetes mellitus	8.84e-05	0.00041	CcSEcCtD
Sparfloxacin—Pruritus—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000409	CcSEcCtD
Sparfloxacin—Malaise—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000407	CcSEcCtD
Sparfloxacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.79e-05	0.000407	CcSEcCtD
Sparfloxacin—Rash—Glyburide—type 2 diabetes mellitus	8.77e-05	0.000406	CcSEcCtD
Sparfloxacin—Somnolence—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.000406	CcSEcCtD
Sparfloxacin—Dermatitis—Glyburide—type 2 diabetes mellitus	8.76e-05	0.000406	CcSEcCtD
Sparfloxacin—Vertigo—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000406	CcSEcCtD
Sparfloxacin—Headache—Glyburide—type 2 diabetes mellitus	8.71e-05	0.000404	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	8.71e-05	0.00236	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	8.71e-05	0.00236	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000402	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	8.66e-05	0.00234	CbGpPWpGaD
Sparfloxacin—Palpitations—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000399	CcSEcCtD
Sparfloxacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.61e-05	0.000399	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—FAS—type 2 diabetes mellitus	8.58e-05	0.00232	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000397	CcSEcCtD
Sparfloxacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.000396	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.54e-05	0.000396	CcSEcCtD
Sparfloxacin—Cough—Ramipril—type 2 diabetes mellitus	8.51e-05	0.000394	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.49e-05	0.0023	CbGpPWpGaD
Sparfloxacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.45e-05	0.000392	CcSEcCtD
Sparfloxacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.45e-05	0.000392	CcSEcCtD
Sparfloxacin—Convulsion—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000391	CcSEcCtD
Sparfloxacin—Constipation—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000391	CcSEcCtD
Sparfloxacin—Pain—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000391	CcSEcCtD
Sparfloxacin—Insomnia—Losartan—type 2 diabetes mellitus	8.39e-05	0.000389	CcSEcCtD
Sparfloxacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.35e-05	0.000387	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—AGER—type 2 diabetes mellitus	8.35e-05	0.00226	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Losartan—type 2 diabetes mellitus	8.33e-05	0.000386	CcSEcCtD
Sparfloxacin—Urticaria—Metformin—type 2 diabetes mellitus	8.3e-05	0.000385	CcSEcCtD
Sparfloxacin—Arthralgia—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000385	CcSEcCtD
Sparfloxacin—Myalgia—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000385	CcSEcCtD
Sparfloxacin—Chest pain—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000385	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	8.3e-05	0.00224	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Losartan—type 2 diabetes mellitus	8.27e-05	0.000383	CcSEcCtD
Sparfloxacin—Anxiety—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000383	CcSEcCtD
Sparfloxacin—Nausea—Glyburide—type 2 diabetes mellitus	8.26e-05	0.000383	CcSEcCtD
Sparfloxacin—Abdominal pain—Metformin—type 2 diabetes mellitus	8.26e-05	0.000383	CcSEcCtD
Sparfloxacin—Dizziness—Gliclazide—type 2 diabetes mellitus	8.26e-05	0.000383	CcSEcCtD
Sparfloxacin—Somnolence—Losartan—type 2 diabetes mellitus	8.25e-05	0.000382	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—type 2 diabetes mellitus	8.24e-05	0.00223	CbGpPWpGaD
Sparfloxacin—Asthenia—Valsartan—type 2 diabetes mellitus	8.23e-05	0.000381	CcSEcCtD
Sparfloxacin—Discomfort—Ramipril—type 2 diabetes mellitus	8.2e-05	0.00038	CcSEcCtD
Sparfloxacin—Dyspepsia—Losartan—type 2 diabetes mellitus	8.17e-05	0.000378	CcSEcCtD
Sparfloxacin—Asthenia—Orlistat—type 2 diabetes mellitus	8.13e-05	0.000377	CcSEcCtD
Sparfloxacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000376	CcSEcCtD
Sparfloxacin—Pruritus—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000376	CcSEcCtD
Sparfloxacin—Dry mouth—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000376	CcSEcCtD
Sparfloxacin—Decreased appetite—Losartan—type 2 diabetes mellitus	8.07e-05	0.000374	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000374	CcSEcCtD
Sparfloxacin—Confusional state—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000372	CcSEcCtD
Sparfloxacin—Pruritus—Orlistat—type 2 diabetes mellitus	8.02e-05	0.000372	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.97e-05	0.00215	CbGpPWpGaD
Sparfloxacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000369	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7.95e-05	0.00215	CbGpPWpGaD
Sparfloxacin—Vomiting—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000368	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	7.94e-05	0.00215	CbGpPWpGaD
Sparfloxacin—Pain—Losartan—type 2 diabetes mellitus	7.93e-05	0.000368	CcSEcCtD
Sparfloxacin—Constipation—Losartan—type 2 diabetes mellitus	7.93e-05	0.000368	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	7.93e-05	0.00215	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—LEP—type 2 diabetes mellitus	7.87e-05	0.00213	CbGpPWpGaD
Sparfloxacin—Rash—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.000365	CcSEcCtD
Sparfloxacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.000364	CcSEcCtD
Sparfloxacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000364	CcSEcCtD
Sparfloxacin—Urticaria—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000363	CcSEcCtD
Sparfloxacin—Headache—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000362	CcSEcCtD
Sparfloxacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000361	CcSEcCtD
Sparfloxacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000361	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000361	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—type 2 diabetes mellitus	7.77e-05	0.0021	CbGpPWpGaD
Sparfloxacin—Tachycardia—Ramipril—type 2 diabetes mellitus	7.76e-05	0.00036	CcSEcCtD
Sparfloxacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000359	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000356	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.68e-05	0.00208	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.65e-05	0.000354	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.59e-05	0.000352	CcSEcCtD
Sparfloxacin—Dizziness—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000351	CcSEcCtD
Sparfloxacin—Anorexia—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000351	CcSEcCtD
Sparfloxacin—Dizziness—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000347	CcSEcCtD
Sparfloxacin—Asthenia—Metformin—type 2 diabetes mellitus	7.5e-05	0.000347	CcSEcCtD
Sparfloxacin—Nausea—Gliclazide—type 2 diabetes mellitus	7.42e-05	0.000344	CcSEcCtD
Sparfloxacin—Pruritus—Metformin—type 2 diabetes mellitus	7.39e-05	0.000342	CcSEcCtD
Sparfloxacin—Urticaria—Losartan—type 2 diabetes mellitus	7.37e-05	0.000342	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.36e-05	0.00199	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	7.34e-05	0.00198	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Losartan—type 2 diabetes mellitus	7.33e-05	0.00034	CcSEcCtD
Sparfloxacin—Body temperature increased—Losartan—type 2 diabetes mellitus	7.33e-05	0.00034	CcSEcCtD
Sparfloxacin—Vomiting—Valsartan—type 2 diabetes mellitus	7.29e-05	0.000338	CcSEcCtD
Sparfloxacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000337	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000336	CcSEcCtD
Sparfloxacin—Rash—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000335	CcSEcCtD
Sparfloxacin—Dermatitis—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000335	CcSEcCtD
Sparfloxacin—Vomiting—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000334	CcSEcCtD
Sparfloxacin—Insomnia—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000333	CcSEcCtD
Sparfloxacin—Headache—Valsartan—type 2 diabetes mellitus	7.19e-05	0.000333	CcSEcCtD
Sparfloxacin—Diarrhoea—Metformin—type 2 diabetes mellitus	7.15e-05	0.000331	CcSEcCtD
Sparfloxacin—Rash—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000331	CcSEcCtD
Sparfloxacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000331	CcSEcCtD
Sparfloxacin—Dermatitis—Orlistat—type 2 diabetes mellitus	7.14e-05	0.000331	CcSEcCtD
Sparfloxacin—Headache—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000329	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.1e-05	0.00192	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.1e-05	0.00192	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000329	CcSEcCtD
Sparfloxacin—Asthenia—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000328	CcSEcCtD
Sparfloxacin—Somnolence—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000328	CcSEcCtD
Sparfloxacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	7e-05	0.000324	CcSEcCtD
Sparfloxacin—Pruritus—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000323	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	6.96e-05	0.00188	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.92e-05	0.00032	CcSEcCtD
Sparfloxacin—Dizziness—Metformin—type 2 diabetes mellitus	6.91e-05	0.00032	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	6.89e-05	0.00186	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	6.86e-05	0.00185	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.84e-05	0.000317	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.84e-05	0.00185	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.84e-05	0.00185	CbGpPWpGaD
Sparfloxacin—Nausea—Valsartan—type 2 diabetes mellitus	6.81e-05	0.000316	CcSEcCtD
Sparfloxacin—Constipation—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000315	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	6.78e-05	0.00183	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000313	CcSEcCtD
Sparfloxacin—Nausea—Orlistat—type 2 diabetes mellitus	6.73e-05	0.000312	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	6.71e-05	0.00182	CbGpPWpGaD
Sparfloxacin—Asthenia—Losartan—type 2 diabetes mellitus	6.66e-05	0.000308	CcSEcCtD
Sparfloxacin—Vomiting—Metformin—type 2 diabetes mellitus	6.64e-05	0.000308	CcSEcCtD
Sparfloxacin—Rash—Metformin—type 2 diabetes mellitus	6.59e-05	0.000305	CcSEcCtD
Sparfloxacin—Dermatitis—Metformin—type 2 diabetes mellitus	6.58e-05	0.000305	CcSEcCtD
Sparfloxacin—Pruritus—Losartan—type 2 diabetes mellitus	6.56e-05	0.000304	CcSEcCtD
Sparfloxacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000304	CcSEcCtD
Sparfloxacin—Headache—Metformin—type 2 diabetes mellitus	6.54e-05	0.000303	CcSEcCtD
Sparfloxacin—Dizziness—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000302	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000301	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—type 2 diabetes mellitus	6.47e-05	0.00175	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.39e-05	0.00173	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	6.36e-05	0.00172	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Losartan—type 2 diabetes mellitus	6.35e-05	0.000294	CcSEcCtD
Sparfloxacin—Urticaria—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000293	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—LEP—type 2 diabetes mellitus	6.32e-05	0.00171	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000291	CcSEcCtD
Sparfloxacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000291	CcSEcCtD
Sparfloxacin—Vomiting—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.00029	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—PSMD6—type 2 diabetes mellitus	6.23e-05	0.00168	CbGpPWpGaD
Sparfloxacin—Rash—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000288	CcSEcCtD
Sparfloxacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000288	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.21e-05	0.00168	CbGpPWpGaD
Sparfloxacin—Nausea—Metformin—type 2 diabetes mellitus	6.21e-05	0.000288	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	6.18e-05	0.00167	CbGpPWpGaD
Sparfloxacin—Headache—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000286	CcSEcCtD
Sparfloxacin—Dizziness—Losartan—type 2 diabetes mellitus	6.14e-05	0.000284	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.1e-05	0.00165	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.1e-05	0.00165	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—FAS—type 2 diabetes mellitus	5.96e-05	0.00161	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.95e-05	0.00161	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.92e-05	0.0016	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	5.92e-05	0.0016	CbGpPWpGaD
Sparfloxacin—Vomiting—Losartan—type 2 diabetes mellitus	5.9e-05	0.000273	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 2 diabetes mellitus	5.89e-05	0.00159	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.88e-05	0.00159	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—C3—type 2 diabetes mellitus	5.88e-05	0.00159	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000272	CcSEcCtD
Sparfloxacin—Nausea—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000271	CcSEcCtD
Sparfloxacin—Rash—Losartan—type 2 diabetes mellitus	5.85e-05	0.000271	CcSEcCtD
Sparfloxacin—Dermatitis—Losartan—type 2 diabetes mellitus	5.84e-05	0.000271	CcSEcCtD
Sparfloxacin—Headache—Losartan—type 2 diabetes mellitus	5.81e-05	0.000269	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.81e-05	0.00157	CbGpPWpGaD
Sparfloxacin—Asthenia—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000264	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	5.68e-05	0.00154	CbGpPWpGaD
Sparfloxacin—Pruritus—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000261	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	5.62e-05	0.00152	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.61e-05	0.00152	CbGpPWpGaD
Sparfloxacin—Nausea—Losartan—type 2 diabetes mellitus	5.51e-05	0.000255	CcSEcCtD
Sparfloxacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000252	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	5.42e-05	0.00147	CbGpPWpGaD
Sparfloxacin—Dizziness—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000244	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	5.25e-05	0.00142	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	5.22e-05	0.00141	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.19e-05	0.0014	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	5.09e-05	0.00138	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—type 2 diabetes mellitus	5.08e-05	0.00137	CbGpPWpGaD
Sparfloxacin—Vomiting—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000234	CcSEcCtD
Sparfloxacin—Rash—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000232	CcSEcCtD
Sparfloxacin—Dermatitis—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000232	CcSEcCtD
Sparfloxacin—Headache—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000231	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	4.96e-05	0.00134	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.95e-05	0.00134	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	4.88e-05	0.00132	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.81e-05	0.0013	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.74e-05	0.00128	CbGpPWpGaD
Sparfloxacin—Nausea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000219	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.67e-05	0.00126	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	4.6e-05	0.00124	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2B—type 2 diabetes mellitus	4.55e-05	0.00123	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	4.55e-05	0.00123	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.46e-05	0.00121	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.46e-05	0.00121	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	4.44e-05	0.0012	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	4.43e-05	0.0012	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.35e-05	0.00118	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.33e-05	0.00117	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.3e-05	0.00116	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	4.28e-05	0.00116	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	4.24e-05	0.00115	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	4.1e-05	0.00111	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	4.1e-05	0.00111	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.09e-05	0.00111	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.07e-05	0.0011	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	4.06e-05	0.0011	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.03e-05	0.00109	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.98e-05	0.00108	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	3.97e-05	0.00107	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.9e-05	0.00105	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.79e-05	0.00103	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.79e-05	0.00103	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	3.76e-05	0.00102	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.75e-05	0.00101	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	3.74e-05	0.00101	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.64e-05	0.000985	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.62e-05	0.000978	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	3.53e-05	0.000954	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	3.48e-05	0.000941	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.47e-05	0.000938	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	3.46e-05	0.000936	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	3.42e-05	0.000926	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	3.41e-05	0.000923	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	3.35e-05	0.000906	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.34e-05	0.000903	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.34e-05	0.000903	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.29e-05	0.000889	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.21e-05	0.000869	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.21e-05	0.000869	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.16e-05	0.000854	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.08e-05	0.000834	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.99e-05	0.000808	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.98e-05	0.000805	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	2.95e-05	0.000799	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.95e-05	0.000797	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	2.94e-05	0.000796	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	2.94e-05	0.000795	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.92e-05	0.000789	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	2.91e-05	0.000787	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.85e-05	0.000771	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.82e-05	0.000764	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.73e-05	0.000739	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	2.72e-05	0.000736	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	2.71e-05	0.000733	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.66e-05	0.00072	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.64e-05	0.000714	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	2.6e-05	0.000704	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	2.53e-05	0.000685	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.53e-05	0.000684	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.44e-05	0.000661	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.4e-05	0.00065	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.38e-05	0.000644	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.38e-05	0.000644	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.27e-05	0.000614	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.26e-05	0.00061	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.26e-05	0.00061	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.25e-05	0.00061	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.23e-05	0.000604	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.2e-05	0.000594	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.18e-05	0.000589	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.15e-05	0.000582	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.1e-05	0.000567	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.1e-05	0.000567	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.05e-05	0.000553	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.03e-05	0.00055	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.02e-05	0.000547	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.99e-05	0.000537	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.99e-05	0.000537	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.95e-05	0.000527	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.92e-05	0.000519	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.92e-05	0.000519	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.92e-05	0.000519	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.92e-05	0.000519	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.92e-05	0.000519	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.86e-05	0.000502	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.85e-05	0.000501	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.79e-05	0.000483	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.78e-05	0.000482	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.75e-05	0.000474	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.75e-05	0.000474	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.72e-05	0.000465	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.71e-05	0.000462	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.7e-05	0.00046	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.63e-05	0.000441	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.63e-05	0.000441	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.63e-05	0.000441	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.63e-05	0.000441	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.61e-05	0.000434	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.56e-05	0.000423	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.56e-05	0.000423	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.51e-05	0.000407	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.51e-05	0.000407	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.5e-05	0.000405	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.48e-05	0.0004	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.46e-05	0.000394	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.45e-05	0.000393	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.45e-05	0.000393	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.45e-05	0.000393	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.41e-05	0.00038	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.4e-05	0.000378	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.39e-05	0.000375	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.37e-05	0.00037	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.34e-05	0.000362	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.34e-05	0.000362	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.31e-05	0.000355	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.28e-05	0.000346	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.25e-05	0.000339	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.25e-05	0.000338	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.24e-05	0.000334	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.24e-05	0.000334	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.24e-05	0.000334	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.24e-05	0.000334	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.19e-05	0.00032	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.13e-05	0.000306	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.1e-05	0.000298	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.06e-05	0.000287	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-05	0.000278	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.01e-05	0.000273	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.01e-05	0.000273	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	9.88e-06	0.000267	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	9.82e-06	0.000266	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	9.82e-06	0.000266	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	9.82e-06	0.000266	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	9.76e-06	0.000264	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.58e-06	0.000259	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	9.47e-06	0.000256	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.3e-06	0.000252	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	8.81e-06	0.000238	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	8.81e-06	0.000238	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	8.81e-06	0.000238	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8.65e-06	0.000234	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	8.57e-06	0.000232	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.4e-06	0.000227	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.38e-06	0.000227	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.06e-06	0.000218	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.97e-06	0.000215	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.97e-06	0.000215	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.77e-06	0.00021	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.64e-06	0.000207	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.64e-06	0.000207	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.58e-06	0.000178	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.58e-06	0.000178	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.55e-06	0.000177	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.46e-06	0.000175	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.28e-06	0.00017	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.1e-06	0.000165	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.99e-06	0.000162	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.87e-06	0.000159	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.85e-06	0.000158	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.69e-06	0.000154	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.62e-06	0.000152	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.4e-06	0.000146	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.29e-06	0.000143	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.13e-06	0.000139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.04e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.02e-06	0.000136	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.97e-06	0.000134	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.38e-06	0.000118	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.29e-06	0.000116	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.93e-06	0.000106	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.76e-06	0.000102	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.76e-06	0.000102	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.44e-06	9.31e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-06	4.68e-05	CbGpPWpGaD
